www.fdanews.com/articles/114066-thrombogenics-bioinvent-get-5-mln-euros-from-roche

ThromboGenics, BioInvent Get 5 Mln Euros From Roche

January 26, 2009

Belgian biotech company ThromboGenics said it had received a payment of 5 million euros ($6.48 million) from Swiss drugmaker Roche for progress in developing anti-cancer drug TB-403.
Yahoo! Finance UK & Ireland